Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Contract Manufacturing
  • Med Tech Resources
    • Video
    • Webinars
    • Whitepapers
    • eBooks
    • Medical Device Handbook
    • Print Subscription
    • Digital Editions
    • Events
    • Podcasts
    • Suppliers
    • Manufacturer Search
    • The Big 100
    • Contact/About Us
  • Leadership
    • 2018 Winners
    • 2017 Winners
    • 2016 Winners

What is the future of medtech in 2018?

December 29, 2017 By Heather Thompson 1 Comment

Share

Value-based care

NEC’s UNIVERGE 3C, a software-based platform. [Photo by NEC Corporation of America with Creative Commons license.]

“I expect in 2018 we will see continued movement away from mandatory payment models and toward voluntary models, with more flexibility and a focus on small-scale testing to understand what is working and what isn’t. At the same time, it will be important to expand participation in advanced APMs (A—APMs), one of the pathways in the Quality Payment Program (QPP). One way the administration might accomplish this is to look to Medicare Advantage innovation models to drive better quality and outcomes, at lower costs.” —Matt Reifenberger, manager, Global Health Economics and Reimbursement, Edwards Lifesciences

“2018 will prove to be a landmark year for wearable technology as it continues to carve out its space within mainstream healthcare. Better analytics and more context around the patient will validate the capabilities of these solutions. Sleek design improvements and enhanced usability will make these innovations more integrated than ever before. With over 117 million diagnosed chronic disease patients in the U.S. since 2012, these individuals will be able to adopt these new technologies in their own homes with zero negative impact on their lifestyle.” —Rachel Mele, general manager of healthcare at Vennli

“This next year we will see considerable progress in the device industry waking up and actually doing more than just talk about the potential of adding ecosystems to support many aspects of their devices and the diseases/conditions they treat. The device side of healthcare has been slower to adopt than say Pharma. But a lot of device makers have now seen the pioneering companies in the device space make meaningful progress to adding genuine value over and above just the devices. Leaders in the field have surrounded their products with ecosystems to support diagnostics, adherence, recovery, supply chain etc, helping with the three legs of the “success” stool: better outcomes, lowering of overall costs (not necessarily of just the device or direct procedure cost), and importantly to help justify investment in ecosystems, also improving customer loyalty and hence uptake of their offerings.” —Bill Evans, SVP innovation, Ximedica San Francisco

Next>>

You may also like:

  • 2017 medtech
    7 top stories that mattered for medtech in 2017
  • patient remote monitoring
    The top 10 medical disruptors of 2018
  • GalienFoundationBestMedTech
    The 11 most innovative medical devices of 2017
Pages: 1 2 3 4 5 6 7 8

Comments

  1. Alok Sharma says

    January 4, 2018 at 4:10 am

    In the year 2018, device industry must cohesively work more with Pharma companies to add value to the life of the patients. The disease and the disease patterns are changing & so the long term outcomes. Doctors / practitioners/ Companies & regulatory authorities must look at the side effects of post implantation of a device and prescribe medications so that long term outcomes of the patients are better with low side effects. Not all patients globally have an insurance Cover. Adipose tissue derived autologous Stem Cells treatment must get speedy approvals from regulatory authorities.

    Reply

Tell Us What You Think! Cancel reply

Related Articles Read More >

IEEE publishes safety standards draft for medtech interoperability
FDA clears Safe Medical Design’s urethral catheter
Complion
Regulatory software company Complion raises $7M
Ametek titanium grade 9 and 23
These new titanium strip grades could enable better neuromodulation devices

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

Enewsletter Subscriptions

Tweets by MedTechDaily

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • Drug Delivery Business News
  • About Us/Contact
  • Advertising
  • Enewsletter
  • Subscribe!

Copyright © 2019 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Contract Manufacturing
  • Med Tech Resources
    • Video
    • Webinars
    • Whitepapers
    • eBooks
    • Medical Device Handbook
    • Print Subscription
    • Digital Editions
    • Events
    • Podcasts
    • Suppliers
    • Manufacturer Search
    • The Big 100
    • Contact/About Us
  • Leadership
    • 2018 Winners
    • 2017 Winners
    • 2016 Winners